Cargando…
Potentiation of combined p19Arf and interferon-beta cancer gene therapy through its association with doxorubicin chemotherapy
Balancing safety and efficacy is a major consideration for cancer treatments, especially when combining cancer immunotherapy with other treatment modalities such as chemotherapy. Approaches that induce immunogenic cell death (ICD) are expected to eliminate cancer cells by direct cell killing as well...
Autores principales: | Medrano, Ruan F. V., Salles, Thiago A., Dariolli, Rafael, Antunes, Fernanda, Feitosa, Valker A., Hunger, Aline, Catani, João P. P., Mendonça, Samir A., Tamura, Rodrigo E., Lana, Marlous G., Rodrigues, Elaine G., Strauss, Bryan E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365852/ https://www.ncbi.nlm.nih.gov/pubmed/35948616 http://dx.doi.org/10.1038/s41598-022-17775-y |
Ejemplares similares
-
Harnessing combined p19Arf and interferon-beta gene transfer as an inducer of immunogenic cell death and mediator of cancer immunotherapy
por: Hunger, Aline, et al.
Publicado: (2017) -
Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma()()
por: Catani, João Paulo Portela, et al.
Publicado: (2016) -
Response of human melanoma cell lines to interferon-beta gene transfer mediated by a modified adenoviral vector
por: David, Taynah I. P., et al.
Publicado: (2020) -
Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death
por: Hunger, Aline, et al.
Publicado: (2017) -
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
por: Medrano, Ruan F.V., et al.
Publicado: (2017)